What's new

Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 9, Status: Authorised

Jun 4, 2025 - 15:00
 0
Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Beqvez (previously Dur...

Next Article

IVF Media G5 - Procedural steps and scientific information after initial consult...

Related Posts

QRD veterinary product-information template version 9.1

Jun 5, 2025  0

Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 28, 2025  0

PSUSA/00001606/202409

PSUSA/00001606/202409

May 13, 2025  0